In this study, we identified nucleotide binding oligomerization domain 2 (NOD2), an innate immune sensor, as an efficient direct regulator of AMPK pathway; and loss of its expression in cancer cells promoted HCC progression and resistance to chemotherapy. This evidence concerns the gene PRKAB1 and hepatocellular carcinoma.